> top > projects > semrep-sample > docs > PubMed:10089140 > annotations
semrep-sample Home  

PubMed:10089140 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
E1-ti-1 13-41 cui:C1456820 denotes tumour necrosis factor alpha
E2-ti-1 42-52 cui:C0185117 denotes expression
E3-ti-1 57-67 cui:C0037083 denotes signalling
T1 68-70 LOCATION_OF denotes in
E4-ti-1 71-105 cui:C1321301 denotes peripheral blood mononuclear cells
E5-ti-1 111-119 cui:C0030705 denotes patients
T2 120-124 PROCESS_OF denotes with
T3 120-124 PROCESS_OF denotes with
T5 120-124 ASSOCIATED_WITH denotes with
T6 120-124 ASSOCIATED_WITH denotes with
E6-ti-1 125-137 cui:C0039730 denotes thalassaemia
E7-ti-1 141-160 cui:C0002895 denotes sickle cell anaemia
E8-ti-1 166-175 cui:C0087111 denotes treatment
T4 176-180 PART_OF denotes with
E9-ti-1 181-196 cui:C0011145 denotes desferrioxamine
E1-ab-1 198-204 cui:C0332185 denotes Recent
E2-ab-1 233-237 cui:C1521828 denotes rate
E3-ab-1 241-252 cui:C0449258 denotes progression
E4-ab-1 260-273 cui:C0019693 denotes HIV-1 disease
T8 299-301 PROCESS_OF denotes in
E5-ab-1 302-320 cui:C0002875 denotes thalassaemia major
T7 302-329 PROCESS_OF denotes thalassaemia major patients
E6-ab-1 321-329 cui:C0030705 denotes patients
E7-ab-1 335-344 cui:C0087111 denotes treatment
E8-ab-1 350-360 cui:C0444956 denotes high doses
E9-ab-1 364-379 cui:C0011145 denotes desferrioxamine
E1-ab-2 391-398 cui:C0221192 denotes authors
E2-ab-2 454-471 cui:C0806987 denotes mononuclear cells
E3-ab-2 475-478 cui:C0011145 denotes DFX
T9 479-488 INHIBITS denotes decreases
E4-ab-2 493-508 cui:C0005508 denotes bioavailability
E5-ab-2 512-540 cui:C1456820 denotes tumour necrosis factor alpha
E6-ab-2 565-576 cui:C0175727 denotes stimulatory
E7-ab-2 577-583 cui:C1280500 denotes effect
E8-ab-2 587-592 cui:C0019704 denotes HIV-1
E1-ab-3 614-619 cui:C0008972 denotes study
E2-ab-3 632-641 cui:C1456820 denotes TNF-alpha
E3-ab-3 642-657 cui:C0005508 denotes bioavailability
T10 658-662 LOCATION_OF denotes from
E4-ab-3 663-680 cui:C0806987 denotes mononuclear cells
T11 690-694 LOCATION_OF denotes from
E5-ab-3 698-706 cui:C0030705 denotes patients
T12 707-711 PROCESS_OF denotes with
E6-ab-3 712-724 cui:C0039730 denotes thalassaemia
E7-ab-3 728-747 cui:C0002895 denotes sickle cell anaemia
E8-ab-3 754-757 cui:C0011145 denotes DFX
E9-ab-3 786-794 cui:C1550501 denotes subjects
E1-ab-4 850-853 cui:C0011145 denotes DFX
E2-ab-4 872-881 cui:C1456820 denotes TNF-alpha
E3-ab-4 882-897 cui:C0005508 denotes bioavailability
E4-ab-4 910-920 cui:C0311403 denotes inhibiting
E5-ab-4 925-937 cui:C0678587 denotes steady state
E6-ab-4 968-980 cui:C0544461 denotes inactivation
T13 989-996 INTERACTS_WITH denotes binding
E7-ab-4 1008-1017 cui:C0439095 denotes TNF-alpha
E8-ab-4 1008-1034 cui:C0255813 denotes TNF-alpha receptor type II
E1-ab-5 1063-1066 cui:C0011145 denotes DFX
E2-ab-5 1110-1119 cui:C0079904 denotes NF-kappaB
E3-ab-5 1123-1143 cui:C0040648 denotes transcription factor
T14 1144-1152 AFFECTS denotes involved
T15 1144-1152 AFFECTS denotes involved
E4-ab-5 1161-1170 cui:C1448177 denotes TNF-alpha
E5-ab-5 1171-1189 cui:C0040649 denotes gene transcription
E6-ab-5 1194-1203 cui:C1448177 denotes TNF-alpha
E7-ab-5 1204-1214 cui:C0037083 denotes signalling
E1-ab-6 1243-1252 cui:C1456820 denotes TNF-alpha
E2-ab-6 1253-1268 cui:C0005508 denotes bioavailability
E3-ab-6 1273-1283 cui:C0037083 denotes signalling
T16 1297-1299 PROCESS_OF denotes in
E4-ab-6 1300-1308 cui:C0030705 denotes patients
E5-ab-6 1314-1317 cui:C0011145 denotes DFX
E1-ab-7 1334-1343 cui:C0441712 denotes mechanism
E2-ab-7 1362-1369 cui:C0205421 denotes delayed
E3-ab-7 1370-1381 cui:C0449258 denotes progression
E4-ab-7 1389-1404 cui:C0019693 denotes HIV-1 infection
R1 E4-ti-1 T1 subjectOf peripheral blood mononuclear cells,in
R10 E6-ti-1 T5 objectOf thalassaemia,with
R11 E9-ti-1 T6 subjectOf desferrioxamine,with
R12 E7-ti-1 T6 objectOf sickle cell anaemia,with
R13 E5-ab-1 T7 subjectOf thalassaemia major,thalassaemia major patients
R14 E6-ab-1 T7 objectOf patients,thalassaemia major patients
R15 E4-ab-1 T8 subjectOf HIV-1 disease,in
R16 E6-ab-1 T8 objectOf patients,in
R17 E3-ab-2 T9 subjectOf DFX,decreases
R18 E5-ab-2 T9 objectOf tumour necrosis factor alpha,decreases
R19 E4-ab-3 T10 subjectOf mononuclear cells,from
R2 E1-ti-1 T1 objectOf tumour necrosis factor alpha,in
R20 E2-ab-3 T10 objectOf TNF-alpha,from
R21 E5-ab-3 T11 subjectOf patients,from
R22 E2-ab-3 T11 objectOf TNF-alpha,from
R23 E6-ab-3 T12 subjectOf thalassaemia,with
R24 E5-ab-3 T12 objectOf patients,with
R25 E2-ab-4 T13 subjectOf TNF-alpha,binding
R26 E8-ab-4 T13 objectOf TNF-alpha receptor type II,binding
R27 E3-ab-5 T14 subjectOf transcription factor,involved
R28 E5-ab-5 T14 objectOf gene transcription,involved
R29 E3-ab-5 T15 subjectOf transcription factor,involved
R3 E6-ti-1 T2 subjectOf thalassaemia,with
R30 E7-ab-5 T15 objectOf signalling,involved
R31 E3-ab-6 T16 subjectOf signalling,in
R32 E4-ab-6 T16 objectOf patients,in
R4 E5-ti-1 T2 objectOf patients,with
R5 E7-ti-1 T3 subjectOf sickle cell anaemia,with
R6 E5-ti-1 T3 objectOf patients,with
R7 E9-ti-1 T4 subjectOf desferrioxamine,with
R8 E5-ti-1 T4 objectOf patients,with
R9 E9-ti-1 T5 subjectOf desferrioxamine,with